20 apr 2017 anni - FDA announced the restricted the use of
codeine and tramadol medicines in children.
On April 20, the FDA approved RoxyBond
(oxycodone hydrochloride), an opioid analgesic
indicated for the management of pain severe
enough to require an opioid analgesic and for
which alternative treatments are inadequate.
RoxyBond is the first immediate-release opioid
analgesic approved with labeling describing its
abuse-deterrent properties consistent with the
FDA’s 2015 Guidance for Industry: Abuse-
Deterrent Opio
